$5.67
-0.22-3.74%
At close: -
$5.67
0.000.00%
After Hours: 4:11 PM EDT
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $-1.53 | $-1.53 | 0.00 % |
Jun 2024 | 2024-07-31 | $-1.70 | $-1.66 | -2.41 % |
Mar 2024 | 2024-04-25 | $-1.80 | $-1.65 | -9.09 % |
Dec 2023 | 2024-02-14 | $-0.55 | $-1.28 | 57.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $11.87M | $10.80M | 9.92 % |
Jun 2024 | 2024-07-31 | $8.65M | $8.85M | -2.19 % |
Mar 2024 | 2024-04-25 | $7.90M | $5.66M | 39.6 % |
Dec 2023 | 2024-02-14 | $77.97M | $60.98M | 27.9 % |
Sage Therapeutics (SAGE) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $-1.53, which hit the estimate of $-1.53.
The Actual Revenue was $11.9M, which beat the estimate of $10.8M.
Browse earnings estimates, EPS, and revenue on all stocks.